Department of Biochemistry & Molecular Biology, Howard University College of Medicine, Washington, District of Columbia, United States.
Division of Lung Diseases, National Institutes of Health (NIH), National Heart, Lung and Blood Institute (NHLBI), Bethesda, United States.
Elife. 2023 Mar 22;12:e86002. doi: 10.7554/eLife.86002.
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional malaise, and cognitive dysfunction that last for months and impact everyday functioning, is referred to as Long COVID under the general category of post-acute sequelae of SARS-CoV-2 infection (PASC). PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation. A better understanding of the pathophysiologic mechanisms underlying PASC is essential to guide prevention and treatment. This review addresses potential mechanisms and hypotheses that connect SARS-CoV-2 infection to long-term health consequences. Comparisons between PASC and other virus-initiated chronic syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome will be addressed. Aligning symptoms with other chronic syndromes and identifying potentially regulated common underlining pathways may be necessary for understanding the true nature of PASC. The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein-Barr and herpes viruses in COVID-19 immune-dysregulated tissue environment, SARS-CoV-2 interactions with host microbiome/virome communities, clotting/coagulation dysregulation, dysfunctional brainstem/vagus nerve signaling, dysautonomia or autonomic dysfunction, ongoing activity of primed immune cells, and autoimmunity due to molecular mimicry between pathogen and host proteins. The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage specific patients.
COVID-19,以持续和新出现的症状为特征,如疲劳、劳累后不适和认知功能障碍,持续数月并影响日常功能,在广义的 SARS-CoV-2 感染后急性后遗症(PASC)类别下被称为长新冠。PASC 高度异质,可能与多系统组织损伤/功能障碍有关,包括急性脑炎、心肺综合征、纤维化、肝胆损伤、胃肠失调、心肌梗死、神经肌肉综合征、神经精神障碍、肺损伤、肾衰竭、中风和血管内皮功能障碍。更好地了解 PASC 背后的病理生理机制对于指导预防和治疗至关重要。本综述探讨了将 SARS-CoV-2 感染与长期健康后果联系起来的潜在机制和假设。还将讨论 PASC 与其他病毒引发的慢性综合征(如肌痛性脑脊髓炎/慢性疲劳综合征和体位性心动过速综合征)之间的关系。将症状与其他慢性综合征进行比较,并确定潜在的调节共同潜在途径,可能对于理解 PASC 的真正性质是必要的。与 PASC 症状相关的讨论贡献者包括急性 SARS-CoV-2 损伤对一个或多个器官的后遗症、几种组织中复制病毒或其残余物的持续储库、潜伏病原体(如 Epstein-Barr 和疱疹病毒)在 COVID-19 免疫失调组织环境中的重新激活、SARS-CoV-2 与宿主微生物组/病毒组群落的相互作用、凝血/凝血功能障碍、脑干/迷走神经信号功能障碍、自主神经功能障碍或自主神经功能障碍、被激活的免疫细胞的持续活动以及由于病原体和宿主蛋白之间的分子模拟而导致的自身免疫。PASC 症状的个体化性质表明,可能需要不同的治疗方法来最好地管理特定患者。